NIH-funded research Fellowship grant

Understanding how certain cells become sperm or egg during early development

Official title: Histone demethylase control of primordial germ cell specification

Funded at University of Wisconsin-Madison · NIH-11140957 · Data updated 2026-11-12

This study is looking at how certain cells in mouse embryos are chosen to become sperm or eggs, focusing on the role of specific proteins in this process, and it aims to help us understand how to support healthy fertility.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Wisconsin-Madison
NIH-funded
Lab location1 site (Madison, United States)
Project startApril 1, 2024
Project endMarch 31, 2027
Funding year2025
Award (this year)$41,423
NIH project number5F31HD113347-02
Project IDNIH-11140957 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals or couples experiencing infertility or developmental issues related to germ cell formation.

Less likely to help

Patients who are not affected by fertility issues or do not have a history of developmental disorders may not benefit from this research.

What this research studies

This research investigates the process by which specific cells in mouse embryos are designated to become primordial germ cells (PGCs), which eventually develop into sperm or eggs. The focus is on understanding the role of histone demethylases in the epigenetic changes that occur during this specification process. By using an in vitro model of PGC-like cell differentiation and advanced sequencing techniques, the research aims to uncover how certain genetic regions are protected from early DNA demethylation, which is crucial for proper germ cell development and fertility.

Why it matters

Potential benefit: If successful, this research could lead to new insights into fertility and developmental disorders, potentially improving reproductive health.

How similar studies have gone: Previous research has shown success in understanding epigenetic modifications in other contexts, suggesting that this approach may yield valuable insights.

Where this research is happening

  • University of Wisconsin-Madison
    Madison, United States
    Active

Researchers

  • Principal investigator: Cormaty, Harshini — University of Wisconsin-Madison
  • Study coordinator: Cormaty, Harshini

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.